Morgan Stanley analyst Nigel Dally maintains Aflac (NYSE:AFL) with a Equal-Weight and raises the price target from $91 to $98.

UBS analyst Brian Meredith maintains Aflac (NYSE:AFL) with a Neutral and raises the price target from $84 to $109.

Jim Cramer suggests buying Applied Materials despite government concerns, Aflac not favored, UnitedHealth Group best, Snap not ...

Wells Fargo analyst Elyse Greenspan maintains Aflac (NYSE:AFL) with a Equal-Weight and raises the price target from $81 to $90.

Truist Securities analyst Mark Hughes maintains Aflac (NYSE:AFL) with a Hold and raises the price target from $82 to $100.

B of A Securities analyst Joshua Shanker maintains Aflac (NYSE:AFL) with a Buy and raises the price target from $105 to $108.

Aflac (NYSE:AFL) reported quarterly earnings of $1.83 per share which beat the analyst consensus estimate of $1.60 by 14.38 per...